LOS ANGELES - A 12-WEEK study of experimental drug dapagliflozin in combination with common oral diabetes drugs and high doses of insulin showed that it controlled glucose better than a placebo in patients with type 2 diabetes, the drug's developers said on Saturday.
The drug, a member of a class known as SGLT2 inhibitors, is currently in Phase 3 trials under joint development by Bristol-Myers Squibb Co and AstraZeneca Plc.
LIMA - RESEARCHERS at an archeological site in northern Peru have made an unusually large discovery of nearly three dozen people sacrificed some 600 years ago by the Incan civilisation.
The bodies, some of which show signs of having been cut along their necks and collarbones, were otherwise found in good condition, said Mr Carlos Webster, who is leading excavations at the Chotuna-Chornancap camp.
